Oxford Nanopore Technologies today announced the expansion of its Compatible Products Programme (CPP), welcoming a new cohort of leading partners whose products now integrate seamlessly with ...

Oxford Nanopore Technologies has teamed up with Cepheid to speed up infectious disease genomic analysis, blocking out recent noise of acquisition vulnerability. The UK biotech, a former star of ...

Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases The two companies have completed a ...

Technologycategory· January 9, 2024 Britain's Oxford Nanopore's shares sink after revenue warning Shares in Britain's Oxford Nanopore dropped nearly 12% on Tuesday, after the sensing technology ...

Oxford Nanopore unveiled an extra £100 million ($140m) in fundraising yesterday, helping it to sustain its ambitions to be a major player in the gene sequencing field. The company is one of the U ...

In this webinar, Dr. Alfredo Hidalgo Miranda will demonstrate the potential and flexibility of Oxford Nanopore Technologies’ sequencing platforms in cancer and infectious disease research. He will ...

Oxford Nanopore Technologies and Cepheid, announced a strategic collaboration to develop and commercialize a seamless end-to-end workflow that combines Cepheid’s GeneXpert system for pre-sequencing ...